Willy Roth
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
Papers in
-
- Analytical Methods in Pharmaceuticals 5
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Joachim Stangier (6 shared papers)Karin Rathgen (4 shared papers)Hildegard Stähle (4 shared papers)Dietmar Ganßer (1 shared paper)Thomas Ebner (5 shared papers)Stefan Blech (1 shared paper)Eva Ludwig-Schwellinger (1 shared paper)Klaus Beschke (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmacy and Pharmacology (2 papers)Pharmacogenetics and Genomics (2 papers)European Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Willy Roth
22 papers receiving 2.2k citations
Willy Roth's Hit Papers
Peers
Comparison fields: 5 of 100
- Internal Medicine 749
- Cardiology and Cardiovascular Medicine 1.3k
- Pharmacology 270
- Analytical Chemistry 153
- Hematology 155
Countries citing papers authored by Willy Roth
This map shows the geographic impact of Willy Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy Roth more than expected).
Fields of papers citing papers by Willy Roth
This network shows the impact of papers produced by Willy Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy Roth. The network helps show where Willy Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Willy Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects Hit paper breakdown → | 2007 | 741 |
| 2 | The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans Hit paper breakdown → | 2007 | 578 |
| 3 | 1981 | 185 | |
| 4 | 2006 | 152 | |
| 5 | 2008 | 145 | |
| 6 | 2009 | 84 | |
| 7 | 2009 | 78 | |
| 8 | 1986 | 71 | |
| 9 | 2008 | 67 | |
| 10 | 2011 | 55 | |
| 11 | 2011 | 49 | |
| 12 | 2000 | 47 | |
| 13 | 1983 | 34 | |
| 14 | 1989 | 32 | |
| 15 | 1979 | 17 | |
| 16 | 2002 | 16 | |
| 17 | 1991 | 16 | |
| 18 | 2006 | 14 | |
| 19 | 1983 | 11 | |
| 20 | 2008 | 11 |
About Willy Roth
Willy Roth is a scholar working on Analytical Chemistry, Pharmacology, Cardiology and Cardiovascular Medicine, Spectroscopy and Pediatrics, Perinatology and Child Health, having authored 22 papers that have together received 2.4k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), Analytical Chemistry and Chromatography (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Internal Medicine (749 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Pharmacology (270 citations), Analytical Chemistry (153 citations) and Hematology (155 citations). Willy Roth has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Ganßer, Thomas Ebner, Stefan Blech, Eva Ludwig-Schwellinger, Klaus Beschke, Friedrich Wilhelm Koss and Rolf Jauch. Their work appears in journals such as The Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Journal of Pharmacy and Pharmacology, Pharmacogenetics and Genomics and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.